Xalkori and Hypoaesthesia - a phase IV clinical study of FDA data

Summary:

Hypoaesthesia is reported as a side effect among people who take Xalkori (crizotinib), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Synthroid, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Hypoaesthesia when taking Xalkori. It is created by eHealthMe based on reports of 9,640 people who have side effects when taking Xalkori from the FDA, and is updated regularly.

What is Xalkori?

Xalkori has active ingredients of crizotinib. eHealthMe is studying from 9,659 Xalkori users. Check the latest studies of Xalkori.

What is Hypoaesthesia?

Hypoaesthesia (reduced sense of touch or sensation) is found to be associated with 2,899 drugs and 3,184 conditions by eHealthMe. Check the latest studies of Hypoaesthesia.

On Jul, 13, 2026

9,640 people reported to have side effects when taking Xalkori.
Among them, 82 people (0.85%) have Hypoaesthesia.

Among these 82 people:

How long have people been on Xalkori when they have Hypoaesthesia? *

What is the gender of people who have Hypoaesthesia when taking Xalkori? *

female: 63.41 %
male: 36.59 %

What is the age of people who have Hypoaesthesia when taking Xalkori? *

What are other drugs people take besides Xalkori? *

What are other side effects people have besides Hypoaesthesia? *

Diarrhea: 29 people, 35.37%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 26 people, 31.71%
Fatigue (feeling of tiredness): 19 people, 23.17%
Nausea (feeling of having an urge to vomit): 19 people, 23.17%
Peripheral Swelling: 17 people, 20.73%
Visual Impairment: 16 people, 19.51%
Weakness: 15 people, 18.29%
Constipation: 15 people, 18.29%
Nausea And Vomiting: 14 people, 17.07%
Taste - Impaired: 12 people, 14.63%

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 42 people, 51.22%
Lung Cancer - Non-Small Cell (lung cancer): 14 people, 17.07%
Lung Cancer Metastatic (lung cancer spreads to other parts): 6 people, 7.32%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 5 people, 6.10%
Diarrhea: 4 people, 4.88%
Stress And Anxiety: 3 people, 3.66%
Neuropathy Peripheral (surface nerve damage): 3 people, 3.66%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 3.66%
Nausea (feeling of having an urge to vomit): 3 people, 3.66%
Insomnia (sleeplessness): 3 people, 3.66%

* Approximation only. Some reports may have incomplete information.

Do you take Xalkori and have Hypoaesthesia?

- Check whether Hypoaesthesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xalkori:

Xalkori (9,659 reports)

Hypoaesthesia treatments and more:

Hypoaesthesia (189,312 reports)

Browse all side effects of Xalkori:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoaesthesia:

Hypoaesthesia (2,899 drugs)

Browse all the conditions that are associated with Hypoaesthesia:

Hypoaesthesia (3,184 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on crizotinib (the active ingredients of Xalkori) and Xalkori (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.